Given its success in melanoma and non‐small cell lung cancer models, we sought to examine whether anti‐PD‐L1 antibody in combination with immRNA might enhance the anti‐tumour efficacy of single treatment in mouse breast cancer model. Here, CD274 is linked to lung cancer.